Medinotec (MDNC) Cash & Equivalents (2022 - 2026)

Medinotec (MDNC) has reported Cash & Equivalents for 5 consecutive years, with $2.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 29.09% year-over-year to $2.5 million; the trailing twelve-month figure through May 2026 stood at $2.5 million (up 29.09% YoY), and the FY2026 full-year result was $2.8 million, changed 0.46% from the prior year.
• Cash & Equivalents slipped to $2.5 million in Q2 2026 per MDNC's latest filing, from $2.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $3.6 million in Q2 2022 and bottomed at $131577.0 in Q1 2022.
• Historically, Cash & Equivalents has averaged $2.6 million across 5 years, with a median of $2.8 million in 2024.
• The widest YoY moves for Cash & Equivalents: up 2048.9% in 2023, down 23.93% in 2023.
• Over 5 years, Cash & Equivalents stood at $2.8 million in 2022, then declined by 5.9% to $2.7 million in 2023, then decreased by 0.08% to $2.7 million in 2024, then increased by 6.74% to $2.9 million in 2025, then dropped by 11.85% to $2.5 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $2.5 million, $2.8 million, and $2.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.